Heart

Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies

The American Journal of Clinical Nutrition

This meta-analysis of 34 observational studies that followed 180,667 participants showed that baseline serum 25(OH)D levels were inversely associated with total number of cardiovascular disease (CVD) events (including myocardial infarction, ischemic heart disease, heart failure, and stroke) and mortality risk. Overall, the risk of CVD events was 10% lower for each 10 ng/mL increase in serum 25(OH)D.

Related Studies

Heart

25-Hydroxyvitamin D Levels and Risk of Ischemic Heart Disease, Myocardial Infarction, and Early Death

Arteriosclerosis, Thrombosis, and Vascular Biology - American Heart Association Journals

This population-based study and meta-analysis found increasing risk of ischemic heart disease, myocardial infarction, and early death with decreasing vitamin D levels. In comparing individuals in the lowest versus highest vitamin D percentiles, risk was increased by 40% for ischemic heart disease, by 64% for myocardial infarction, by 57% for early death, and by 81% for fatal ischemic heart disease/myocardial infarction.

Heart

25-Hydroxyvitamin D Levels and Risk of Ischemic Heart Disease, Myocardial Infarction, and Early Death

Arteriosclerosis, Thrombosis, and Vascular Biology - American Heart Association Journals

This population-based study and meta-analysis found increasing risk of ischemic heart disease, myocardial infarction, and early death with decreasing vitamin D levels. In comparing individuals in the lowest versus highest vitamin D percentiles, risk was increased by 40% for ischemic heart disease, by 64% for myocardial infarction, by 57% for early death, and by 81% for fatal ischemic heart disease/myocardial infarction.

Heart

Low sun exposure habits is associated with a dose‑dependent increased risk of hypertension: a report from the large MISS cohort

Photochemical & Photobiological Sciences

This observational study involving 23,593 women found that sun exposure was associated with a dose-dependent reduced risk of hypertension, which might partly explain the fewer deaths of cardiovascular disease with increasing sun exposure. As compared to those women with the greatest sun exposure, women with low and moderate sun exposure were at 41% and 15% higher odds of hypertension.

Heart

Low sun exposure habits is associated with a dose‑dependent increased risk of hypertension: a report from the large MISS cohort

Photochemical & Photobiological Sciences

This observational study involving 23,593 women found that sun exposure was associated with a dose-dependent reduced risk of hypertension, which might partly explain the fewer deaths of cardiovascular disease with increasing sun exposure. As compared to those women with the greatest sun exposure, women with low and moderate sun exposure were at 41% and 15% higher odds of hypertension.

Heart

Impact of ultraviolet radiation on cardiovascular and metabolic disorders: The role of nitric oxide and vitamin D

Photodermatology, Photoimmunology & Photomedicine

UVB exposure can influence cardiovascular and metabolic health through nitric oxide (NO)–mediated pathways that do not require vitamin D synthesis.This review summarizes the systemic effects of UV radiation on hypertension and several metabolic diseases such as obesity and diabetes. UVB stimulates NO production in the skin, which enters circulation to promote vasodilation, lower blood pressure, and reduce cardiovascular risk.

Heart

Impact of ultraviolet radiation on cardiovascular and metabolic disorders: The role of nitric oxide and vitamin D

Photodermatology, Photoimmunology & Photomedicine

UVB exposure can influence cardiovascular and metabolic health through nitric oxide (NO)–mediated pathways that do not require vitamin D synthesis.This review summarizes the systemic effects of UV radiation on hypertension and several metabolic diseases such as obesity and diabetes. UVB stimulates NO production in the skin, which enters circulation to promote vasodilation, lower blood pressure, and reduce cardiovascular risk.

Get Started

Support

Partner

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.

Get Started

Support

Partner

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.

Get Started

Support

Partner

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.